Weiner S M, Prasauskas V, Lebrecht D, Weber S, Peter H H, Vaith P
Department of Rheumatology and Clinical Immunology, Medical University Clinic, Freiburg, Germany.
Clin Exp Immunol. 2001 Aug;125(2):316-22. doi: 10.1046/j.1365-2249.2001.01606.x.
A previous case report described the formation of a complex between a monoclonal IgA with cryolabile properties and C-reactive protein (CRP). Our study provides the first evidence for the frequent occurrence of CRP in cryoglobulins (Cg) of all three types according to Brouet's classification. We performed a systematic immunochemical analysis of cryoglobulins from 18 patients by Western blotting and in 15 of 18 cryoprecipitates a single band (23 KD), immunoreactive with anti-CRP antibody, was demonstrable irrespective of the clonal composition of the cryoglobulins. This band was detectable in 4/5 of type I, in 6/8 of type II, and in 5/5 of type III cryoprecipitates, classified according to Brouet et al. In addition, the complement proteins C1q and C3 were present in nearly all CRP-containing cryoglobulins, presumably reflecting previous activation of the classical complement pathway at least. All three CRP-negative cryoprecipitates were derived from sera with low cryoglobulin content (1-2 g/l). Longitudinal investigation of 23 cryoprecipitates from seven patients confirmed that successful detection of CRP by Western blotting depends on the protein concentration of the cryoglobulins. Since complexed CRP was previously shown to be an effective activator of complement, via C1q binding, CRP may modulate pathophysiologic effects mediated by cryoglobulins in vivo.
之前的一份病例报告描述了一种具有冷不稳定特性的单克隆IgA与C反应蛋白(CRP)之间形成的复合物。我们的研究首次证明了根据布鲁埃分类法,CRP在所有三种类型的冷球蛋白(Cg)中频繁出现。我们通过蛋白质印迹法对18例患者的冷球蛋白进行了系统的免疫化学分析,在18份冷沉淀物中的15份中,无论冷球蛋白的克隆组成如何,均可检测到一条与抗CRP抗体发生免疫反应的单一条带(23 KD)。根据布鲁埃等人的分类,这条带在I型冷沉淀物的4/5、II型冷沉淀物的6/8和III型冷沉淀物的5/5中均可检测到。此外,补体蛋白C1q和C3几乎存在于所有含CRP的冷球蛋白中,这大概至少反映了经典补体途径先前的激活。所有三份不含CRP的冷沉淀物均来自冷球蛋白含量较低(1 - 2 g/l)的血清。对7例患者的23份冷沉淀物进行的纵向研究证实,通过蛋白质印迹法成功检测CRP取决于冷球蛋白的蛋白质浓度。由于先前已证明复合CRP通过C1q结合是补体的有效激活剂,因此CRP可能在体内调节冷球蛋白介导的病理生理效应。